Bispecific antibody therapy is transforming cancer treatment, especially in multiple myeloma, with ongoing studies exploring early-line and maintenance use.
AstraZeneca Pharma India rose 1.10% to Rs 10,754 after the firm received approval from the Central Drugs Standard Control Organisation (CDSCO) to import pharmaceutical formulations of eculizumab ...
As the first and most advanced cellular therapy centre in the UAE, the UC-MSCs used for this therapy were fully produced at ADSCC’s advanced laboratories ...